Format

Send to

Choose Destination
Cell Death Differ. 2012 Jul;19(7):1187-95. doi: 10.1038/cdd.2011.208. Epub 2012 Jan 20.

A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency.

Author information

1
MedImmune Ltd., Granta Park, Cambridge, UK.

Abstract

Receptor agonism remains poorly understood at the molecular and mechanistic level. In this study, we identified a fully human anti-Fas antibody that could efficiently trigger apoptosis and therefore function as a potent agonist. Protein engineering and crystallography were used to mechanistically understand the agonistic activity of the antibody. The crystal structure of the complex was determined at 1.9 Å resolution and provided insights into epitope recognition and comparisons with the natural ligand FasL (Fas ligand). When we affinity-matured the agonist antibody, we observed that, surprisingly, the higher-affinity antibodies demonstrated a significant reduction, rather than an increase, in agonist activity at the Fas receptor. We propose and experimentally demonstrate a model to explain this non-intuitive impact of affinity on agonist antibody signalling and explore the implications for the discovery of therapeutic agonists in general.

PMID:
22261618
PMCID:
PMC3374083
DOI:
10.1038/cdd.2011.208
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center